Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2026 ▲▼ | Q3 2026 ▲▼ | Change ▲▼ | Q2 2026 ▲▼ | Q3 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| GH Research PLC(GHRS) | 13,263,288 | 13,263,288 | 0 | $356.52M | $311.42M | 48.20% | -$45.10M |
| Cullinan Therapeutics Inc | 8,963,500 | 8,963,500 | 0 | $163.23M | $137.59M | 21.30% | -$25.64M |
| Stoke Therapeutics, Inc.(STOK) | 4,038,404 | 3,896,169 | -142,235 | $132.14M | $101.30M | 15.68% | -$30.84M |
| C4 Therapeutics Inc | 7,326,691 | 7,530,915 | +204,224 | $34.22M | $25.08M | 3.88% | -$9.14M |
| Precision Biosciences Inc | 950,466 | 2,758,215 | +1,807,749 | $7.47M | $17.27M | 2.67% | +$9.80M |
| Agios Pharmaceuticals, Inc.(AGIO) | 3,408,937 | 472,606 | -2,936,331 | $126.51M | $15.71M | 2.43% | -$110.79M |
| Korro Bio Inc | 1,538,296 | 1,544,980 | +6,684 | $20.27M | $15.31M | 2.37% | -$4.96M |
| Neuphoria Therapeutics Inc | 875,328 | 875,328 | 0 | $3.83M | $3.12M | 0.48% | -$709.0K |
| Passage Bio Inc | 673,759 | 673,759 | 0 | $3.29M | $3.03M | 0.47% | -$256.0K |
| Proqr Thrapeutics N VSHS EURO SHS EURO | 521,413 | 1,562,093 | +1,040,680 | $969.8K | $2.59M | 0.40% | +$1.62M |
| Tscan Therapeutics Inc | 8,019,148 | 8,019,148 | 0 | $7.86M | $2.52M | 0.39% | -$5.34M |
| Kazia Therapeutics LtdADS | 0 | 225,800 | +225,800 | $0 | $2.17M | 0.34% | +$2.17M |
| Pliant Therapeutics Inc | 1,798,070 | 1,798,070 | 0 | $2.05M | $1.94M | 0.30% | -$107.9K |
| Entrada Therapeutics Inc | 178,606 | 278,606 | +100,000 | $1.31M | $1.77M | 0.27% | +$454.6K |
| Surrozen Inc | 0 | 20,000 | +20,000 | $0 | $643.6K | 0.10% | +$643.6K |
| Immatics N.V.SHS(IMTX) | 23,236 | 71,263 | +48,027 | $235.4K | $625.7K | 0.10% | +$390.3K |
| Werewolf Therapeutics Inc | 657,786 | 657,786 | 0 | $236.7K | $606.7K | 0.09% | +$369.9K |
| Yarrow Bioscience Inc | 0 | 22,000 | +22,000 | $0 | $495.4K | 0.08% | +$495.4K |
| Xencor, Inc.(XNCR) | 18,194 | 18,194 | 0 | $292.9K | $453.9K | 0.07% | +$161.0K |
| Immunocore Holdings plcADS(IMCR) | 0 | 14,300 | +14,300 | $0 | $433.1K | 0.07% | +$433.1K |
| Dyne Therapeutics, Inc.(DYN) | 0 | 25,000 | +25,000 | $0 | $402.8K | 0.06% | +$402.8K |
| Traws Pharma Inc | 559,470 | 559,470 | 0 | $471.8K | $332.2K | 0.05% | -$139.6K |
| Denali Therapeutics Inc.(DNLI) | 11,658 | 11,658 | 0 | $299.8K | $241.0K | 0.04% | -$58.9K |
| Absci Corporation | 21,245 | 21,245 | 0 | $246.2K | $228.8K | 0.04% | -$17.4K |
| Foghorn Therapeutics Inc | 61,588 | 61,588 | 0 | $300.5K | $219.9K | 0.03% | -$80.7K |
| Avalo Therapeutics Inc | 10,100 | 10,100 | 0 | $186.6K | $154.8K | 0.02% | -$31.8K |
| Prime Medicine, Inc.(PRME) | 0 | 45,000 | +45,000 | $0 | $137.5K | 0.02% | +$137.5K |
| Bolt Biotherapeutics Inc | 30,800 | 30,800 | 0 | $118.6K | $113.3K | 0.02% | -$5.2K |
| Eupraxia Pharmaceuticals Inc | 10,000 | 10,000 | 0 | $66.1K | $91.0K | 0.01% | +$24.9K |
| Nuvation Bio Inc.CL A(NUVB) | 16,029 | 16,029 | 0 | $91.0K | $89.8K | 0.01% | -$1.3K |
| Inhibikase Therapeutics Inc | 20,000 | 20,000 | 0 | $40.6K | $1.2K | 0.00% | -$39.4K |
| CG Oncology, Inc.(CGON) | 31,391 | 0 | -31,391 | $2.23M | $0 | — | -$2.23M |
| Yarrow Bioscience Inc(YARW) | 1,628,700 | 0 | -1,628,700 | $1.06M | $0 | — | -$1.06M |